Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin

8-hydroxy-2-(di-n-propylamino)tetralin and sdz glc 756

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with sdz glc 756 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Laengle, UW; Markstein, R; Nogues, V; Provencher-Bollinger, A; Roman, D; Trendelenburg, AU	1

Other Studies

1 other study(ies) available for 8-hydroxy-2-(di-n-propylamino)tetralin and sdz glc 756

Article	Year
GLC756 decreases TNF-alpha via an alpha2 and beta2 adrenoceptor related mechanism. Experimental eye research, 2006, Volume: 83, Issue:5 Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Lipopolysaccharides; Medetomidine; Propanolamines; Quinolines; Rats; Rats, Inbred Lew; Receptors, Adrenergic; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-2; Receptors, Dopamine D1; Receptors, Dopamine D2; Serotonin 5-HT1 Receptor Antagonists; Serotonin Receptor Agonists; Tumor Necrosis Factor-alpha; Uveitis	2006

Article

Year

GLC756 decreases TNF-alpha via an alpha2 and beta2 adrenoceptor related mechanism.

Experimental eye research, 2006, Volume: 83, Issue:5

Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Lipopolysaccharides; Medetomidine; Propanolamines; Quinolines; Rats; Rats, Inbred Lew; Receptors, Adrenergic; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-2; Receptors, Dopamine D1; Receptors, Dopamine D2; Serotonin 5-HT1 Receptor Antagonists; Serotonin Receptor Agonists; Tumor Necrosis Factor-alpha; Uveitis

2006